Sars-cov-2 mrna (tozinameran 6m-4y) vaccine Pregnancy and Breastfeeding Warnings
Sars-cov-2 mrna (tozinameran 6m-4y) vaccine Pregnancy Warnings
The manufacturer makes no recommendation regarding use during pregnancy.
Animal studies of a dose equivalent to a single human dose given on 4 occasions (twice prior to mating and twice during gestation) showed no evidence of developmental harm to the fetus. There are no controlled data in human pregnancy.
Sars-cov-2 mrna (tozinameran 6m-4y) vaccine Breastfeeding Warnings
The manufacturer makes no recommendation regarding use during lactation.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments:
-There is no information regarding this drug on the presence in human milk, the effects on a breastfed infant, or effects on milk production.
-The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for this medication as well as any potential adverse effects from this drug or the underlying maternal condition.
References for pregnancy information
- (2022) "Product Information. Comirnaty Children 6 months - 4 years (SARS-CoV-2 mRNA (tozinameran 6m-4y) vaccine)." Pfizer Ltd
References for breastfeeding information
- (2022) "Product Information. Comirnaty Children 6 months - 4 years (SARS-CoV-2 mRNA (tozinameran 6m-4y) vaccine)." Pfizer Ltd
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.